Prevention of recurrent Clostridioides difficile infection by fecal microbiota, live-jslm (REBYOTA®) administered via colonoscopy: 6-month data from the single-arm phase IIIb CDI-SCOPE trial.
Saved in:
| Title: | Prevention of recurrent Clostridioides difficile infection by fecal microbiota, live-jslm (REBYOTA®) administered via colonoscopy: 6-month data from the single-arm phase IIIb CDI-SCOPE trial. |
|---|---|
| Authors: | Khanna S; Mayo Clinic, Rochester, 200 First St SW, Rochester, MN 55905, USA., Yoho D; Mid-Atlantic Permanente Medical Group, Springfield, VA, USA., Van Handel D; MNGI Digestive Health, Minneapolis, MN, USA., Clark BJ; Ferring Pharmaceuticals A/S, Copenhagen, Denmark., Awad T; Ferring Pharmaceuticals A/S, Copenhagen, Denmark., Guthmueller B; Ferring Pharmaceuticals, Inc., Parsippany, NJ, USA., Armandi D; Ferring Pharmaceuticals A/S, Copenhagen, Denmark., Knapple W; Arkansas Gastroenterology, North Little Rock, AR, USA., Safdar N; University of Wisconsin, Madison, WI, USA., Baggott B; Cleveland Clinic, Cleveland, OH, USA., Simon K; Om Research, Camarillo, CA, USA., Feuerstadt P; PACT Gastroenterology Center, Yale School of Medicine, Hamden, CT, USA. |
| Source: | Therapeutic advances in gastroenterology [Ther Adv Gastroenterol] 2025 Nov 09; Vol. 18, pp. 17562848251396744. Date of Electronic Publication: 2025 Nov 09 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Publications Country of Publication: England NLM ID: 101478893 Publication Model: eCollection Cited Medium: Print ISSN: 1756-283X (Print) Linking ISSN: 1756283X NLM ISO Abbreviation: Ther Adv Gastroenterol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41230019 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Prevention of recurrent Clostridioides difficile infection by fecal microbiota, live-jslm (REBYOTA<superscript>®</superscript>) administered via colonoscopy: 6-month data from the single-arm phase IIIb CDI-SCOPE trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Khanna+S%22">Khanna S</searchLink>; Mayo Clinic, Rochester, 200 First St SW, Rochester, MN 55905, USA.<br /><searchLink fieldCode="AU" term="%22Yoho+D%22">Yoho D</searchLink>; Mid-Atlantic Permanente Medical Group, Springfield, VA, USA.<br /><searchLink fieldCode="AU" term="%22Van+Handel+D%22">Van Handel D</searchLink>; MNGI Digestive Health, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Clark+BJ%22">Clark BJ</searchLink>; Ferring Pharmaceuticals A/S, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Awad+T%22">Awad T</searchLink>; Ferring Pharmaceuticals A/S, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Guthmueller+B%22">Guthmueller B</searchLink>; Ferring Pharmaceuticals, Inc., Parsippany, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Armandi+D%22">Armandi D</searchLink>; Ferring Pharmaceuticals A/S, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Knapple+W%22">Knapple W</searchLink>; Arkansas Gastroenterology, North Little Rock, AR, USA.<br /><searchLink fieldCode="AU" term="%22Safdar+N%22">Safdar N</searchLink>; University of Wisconsin, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Baggott+B%22">Baggott B</searchLink>; Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Simon+K%22">Simon K</searchLink>; Om Research, Camarillo, CA, USA.<br /><searchLink fieldCode="AU" term="%22Feuerstadt+P%22">Feuerstadt P</searchLink>; PACT Gastroenterology Center, Yale School of Medicine, Hamden, CT, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101478893%22">Therapeutic advances in gastroenterology</searchLink> [Ther Adv Gastroenterol] 2025 Nov 09; Vol. 18, pp. 17562848251396744. <i>Date of Electronic Publication: </i>2025 Nov 09 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage+Publications%22">Sage Publications </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101478893 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1756-283X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221756283X%22">1756283X </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Gastroenterol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41230019 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1177/17562848251396744 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 17562848251396744 Titles: – TitleFull: Prevention of recurrent Clostridioides difficile infection by fecal microbiota, live-jslm (REBYOTA®) administered via colonoscopy: 6-month data from the single-arm phase IIIb CDI-SCOPE trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Khanna S – PersonEntity: Name: NameFull: Yoho D – PersonEntity: Name: NameFull: Van Handel D – PersonEntity: Name: NameFull: Clark BJ – PersonEntity: Name: NameFull: Awad T – PersonEntity: Name: NameFull: Guthmueller B – PersonEntity: Name: NameFull: Armandi D – PersonEntity: Name: NameFull: Knapple W – PersonEntity: Name: NameFull: Safdar N – PersonEntity: Name: NameFull: Baggott B – PersonEntity: Name: NameFull: Simon K – PersonEntity: Name: NameFull: Feuerstadt P IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 11 Text: 2025 Nov 09 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 1756-283X Numbering: – Type: volume Value: 18 Titles: – TitleFull: Therapeutic advances in gastroenterology Type: main |
| ResultId | 1 |